Vanderbilt University
Sequential pembrolizumab may be optimal timing with chemoradiotherapy in head/neck cancer
CHICAGO — A sequential schedule of fixed-dose pembrolizumab with chemoradiotherapy conferred numerically higher PFS rates vs. concurrent timing of the drug among patients with locally advanced head and neck cancer, study results showed.
No-implant interatrial shunt improves HF symptoms with durability at 1 year
ATLANTA – A no-implant interatrial shunt improved HF symptoms including exercise capacity, quality of life and NYHA class at 3 and 6 months, a speaker reported.
10-second videos help predict relapse after hematopoietic stem cell transplantation
Ten-second videos of white blood cell motion in the skin’s microvasculature considerably improved the ability to predict whether blood cancer would relapse after hematopoietic stem cell transplantation, according to study results.
Researchers outline framework to address rising rates of early-onset colorectal cancer
Worldwide prevalence of sporadic colorectal cancer— long viewed as a disease of older individuals — has increased steadily among those aged younger than 50 years during the past decade, according to a review paper in The Lancet Oncology.
Lesbian, gay, bisexual, queer adults have high rates of adverse childhood experiences
Lesbian, gay, bisexual and queer people had higher exposure to all adverse childhood experiences compared with heterosexual adults, according to a cross-sectional study in a research letter published in JAMA Psychiatry.
Critical race theory in cancer research: Ask yourself ‘who is missing’
Critical race theory originated in a legal framework but has implications in the conduct of cancer research, according to Mya L. Roberson, PhD.
Baricitinib reduces mortality in patients with COVID-19 on mechanical ventilation, ECMO
Treatment with baricitinib reduced mortality in critically ill patients with COVID-19 receiving invasive mechanical ventilation or extracorporeal membrane oxygenation, researchers reported in The Lancet Respiratory Medicine.
Every Deep-Drawn Breath with E. Wes Ely, MD, MPH
In this episode, E. Wes Ely, MD, MPH, discusses the value of human connection with patients, reflects on the values of hope and mercy in patient care, and reads key excerpts from his book, Every Deep-Drawn Breath.
Apixaban may be safer for older patients with AF vs. rivaroxaban
Anticoagulation with rivaroxaban for patients with atrial fibrillation aged 65 years or more was associated with greater risk for major ischemic and hemorrhagic events compared with apixaban, according to data published in JAMA.
Smoking outcomes significantly improve risk prediction for atherosclerotic CVD
A retrospective analysis published in JAMA Cardiology found significant improvement in atherosclerotic CVD risk prediction among participants with former smoking, pack-years and years since quitting.